Chemox Pharma is a leading global supplier and manufacturer of (3S)-3-[4-[(2-Chloro-5-iodophenyl) methyl] phenoxy] tetrahydrofuran (CAS No.: 915095-94-2), which is an ISO 9001:2015 certified company based in India. Chemox Pharma provides with high-quality API and Intermediates for research and development and full-scale commercial production. Chemox Pharma meets all global regulatory requirements and delivers every molecule with consistency and highest purity. . Chemox Pharma understands the importance of quality assurance, transparency and strict regulatory compliance thus, we are committed to source Cas No: 915095-94-2 with full document support.
Contact us if you are looking for trustable supplier for (3S)-3-[4-[(2-Chloro-5-iodophenyl) methyl] phenoxy] tetrahydrofuran (CAS No.: 915095-94-2) to experience smooth sourcing of intermediates, affordable pricing and regulatory excellence as per you needs. Chemox Pharma has well equipped R&D Centre mainly focusing on process development, quality improvement and cost optimization. Chemox Pharma provides competitive price solutions that meets the requirement of global pharmaceutical industries
| Sr. No. | Description | Application |
|---|---|---|
| 1 | Chiral tetrahydrofuran intermediate | API synthesis |
| 2 | Halogenated aromatic ether building block | Medicinal chemistry |
| 3 | Enantiomerically pure heterocyclic intermediate | Pharmaceutical R&D |
| 4 | Iodo-chloro substituted aromatic intermediate | Drug development |
| 5 | Specialty chiral intermediate | Fine chemical synthesis |
This compound is widely used in pharmaceutical research and development as a chiral halogenated aromatic tetrahydrofuran intermediate.
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran should be handled according to standard pharmaceutical intermediate and laboratory chemical safety procedures. Appropriate industrial hygiene and protective measures must be followed during handling and synthesis operations.
Use appropriate personal protective equipment (PPE)
Avoid inhalation of dust and contact with skin or eyes
Handle in controlled, well-ventilated environments
Follow chemical handling and containment protocols
Refer to Safety Data Sheet (SDS) for detailed safety information
This compound is intended strictly for pharmaceutical intermediate and research use.
As a chiral pharmaceutical intermediate, (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran does not exhibit direct pharmacological activity. It functions as an enantiomerically pure tetrahydrofuran-aryl ether building block in multi-step organic synthesis pathways for active pharmaceutical ingredients. The iodine and chlorine substituents enable selective substitution and cross-coupling reactions, while the chiral tetrahydrofuran ring contributes stereochemical control in medicinal chemistry and drug development.
Handle in approved chemical or pharmaceutical facilities
Avoid exposure without protective equipment
Prevent dust formation and inhalation
Follow laboratory and industrial safety procedures
Dispose according to regulatory guidelines
Store in tightly closed containers
Protect from moisture and light
Maintain cool, dry storage conditions
Keep in designated chemical storage areas
Follow standard warehouse practices
It is a chiral aromatic pharmaceutical intermediate used in advanced API synthesis, medicinal chemistry research, and development of specialty drug compounds.
Yes, Chemox Pharma manufactures and supplies (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran with high purity for pharmaceutical synthesis applications.
It is a chiral tetrahydrofuran-aryl ether intermediate containing chloro and iodo aromatic substituents used as a building block in pharmaceutical synthesis.
No, it is a pharmaceutical intermediate used in API synthesis and does not exhibit direct therapeutic activity.
It should be stored in tightly sealed containers in a cool, dry place protected from moisture and light, following standard chemical storage practices.
Acotiamide is primarily associated with the management and research of functional dyspepsia and gastric motility disorders, particularly conditions involving impaired gastric accommodation,
Product Name: Lomustine Grade: USP/EP Therapeutic Category: Anti-Neoplastic (Anti-Cancer) CAS Number: 13010-47-4 IH-DMF: N/A Molecular Formula: C₉H₁₆ClN₃O₂ Molecular Weight: 233.70 g/mol Appearance:
Chemox Pharma is a leading and a top Deferoxamine Mesylate manufacturer in India, supplying high-quality pharmaceutical-grade APIs to global markets. Deferoxamine Mesylate
